'Patent Box' Legislation Attracts GSK to Invest $776 Million in U.K.

Legislation proposed this week by the U.K. government to encourage the development of intellectual property (IP) and manufacturing in the U.K. has led GlaxoSmithKline (GSK) to announce a £500 million ($776 million) investment in R&D and manufacturing in the country.   GSK’s package of planned investments features a £50 million U.K. venture capital fund for early stage healthcare companies and university spin outs; formation of a green chemistry academy at the University of Nottingham (Nottingham, U.K.); additional investment in...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers